{
  "kind": "framework",
  "value": "3-3-dose-escalation",
  "collectionKey": "slides:framework:3-3-dose-escalation:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 1,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de071-3fcc-709d-bd81-493d670a1b54",
      "docSlug": "75c0ef2784bf914c01a48398bea9ca14",
      "documentTitle": "Caribou Biosciences | IPO Presentation Deck | 44 slides",
      "authorId": "caribou-biosciences",
      "authorName": "Caribou Biosciences",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investment_bank",
      "sourceTypeLabel": "Investment bank",
      "presentationDate": "2021-07-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7744917,
      "pageNumber": 24,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a standard 3+3 dose escalation clinical trial design.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly mentioned in the diagram",
      "slideHref": "/slides/019de071-3fcc-709d-bd81-493d670a1b54/24",
      "deckHref": "/decks/019de071-3fcc-709d-bd81-493d670a1b54",
      "deckAnchorHref": "/decks/019de071-3fcc-709d-bd81-493d670a1b54#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 15,
          "beatId": "06e1eeef-f9ed-48e8-9be8-6ff4bbd93b58",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Traction is presented on pages 15-36",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}